学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
2',3'-DIDEOXYNUCLEOSIDE PHOSPHORYLATION BY DEOXYCYTIDINE KINASE FROM NORMAL HUMAN THYMUS EXTRACTS - ACTIVATION OF POTENTIAL-DRUGS FOR AIDS THERAPY
被引:34
作者
:
JOHNSON, MA
论文数:
0
引用数:
0
h-index:
0
机构:
ST JUDE CHILDRENS RES HOSP,DEPT BIOCHEM & CLIN PHARMACOL,MEMPHIS,TN 38105
JOHNSON, MA
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
ST JUDE CHILDRENS RES HOSP,DEPT BIOCHEM & CLIN PHARMACOL,MEMPHIS,TN 38105
JOHNS, DG
FRIDLAND, A
论文数:
0
引用数:
0
h-index:
0
机构:
ST JUDE CHILDRENS RES HOSP,DEPT BIOCHEM & CLIN PHARMACOL,MEMPHIS,TN 38105
FRIDLAND, A
机构
:
[1]
ST JUDE CHILDRENS RES HOSP,DEPT BIOCHEM & CLIN PHARMACOL,MEMPHIS,TN 38105
[2]
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20897
来源
:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
|
1987年
/ 148卷
/ 03期
关键词
:
D O I
:
10.1016/S0006-291X(87)80267-X
中图分类号
:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号
:
071010 ;
081704 ;
摘要
:
引用
收藏
页码:1252 / 1258
页数:7
相关论文
共 18 条
[1]
BOTH 2',3'-DIDEOXYTHYMIDINE AND ITS 2',3'-UNSATURATED DERIVATIVE (2',3'-DI-DEOXYTHYMIDINENE) ARE POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION INVITRO
BABA, M
论文数:
0
引用数:
0
h-index:
0
BABA, M
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
PAUWELS, R
HERDEWIJN, P
论文数:
0
引用数:
0
h-index:
0
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
DECLERCQ, E
DESMYTER, J
论文数:
0
引用数:
0
h-index:
0
DESMYTER, J
VANDEPUTTE, M
论文数:
0
引用数:
0
h-index:
0
VANDEPUTTE, M
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1987,
142
(01)
: 128
-
134
[2]
SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) BY 3'-AZIDO-2',3'-DIDEOXYGUANOSINE INVITRO
BABA, M
论文数:
0
引用数:
0
h-index:
0
BABA, M
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
PAUWELS, R
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
BALZARINI, J
HERDEWIJN, P
论文数:
0
引用数:
0
h-index:
0
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
DECLERCQ, E
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1987,
145
(03)
: 1080
-
1086
[3]
THE 2',3'-DIDEOXYRIBOSIDE OF 2,6-DIAMINOPURINE SELECTIVELY INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REPLICATION INVITRO
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
BALZARINI, J
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
PAUWELS, R
BABA, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
BABA, M
ROBINS, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
ROBINS, MJ
ZOU, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
ZOU, R
论文数:
引用数:
h-index:
机构:
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
DECLERCQ, E
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1987,
145
(01)
: 269
-
276
[4]
POTENT AND SELECTIVE ANTI-HTLV-III/LAV ACTIVITY OF 2',3'-DIDEOXYCYTIDINENE, THE 2',3'-UNSATURATED DERIVATIVE OF 2',3'-DIDEOXYCYTIDINE
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BALZARINI, J
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
PAUWELS, R
HERDEWIJN, P
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DECLERCQ, E
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
COONEY, DA
KANG, GJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
KANG, GJ
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DALAL, M
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
JOHNS, DG
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BRODER, S
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1986,
140
(02)
: 735
-
742
[5]
BALZARINI J, 1987, MOL PHARMACOL, V32, P162
[6]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]
CARSON DA, 1980, J IMMUNOL, V124, P8
[8]
LYMPHO-SPECIFIC TOXICITY IN ADENOSINE-DEAMINASE DEFICIENCY AND PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY - POSSIBLE ROLE OF NUCLEOSIDE KINASE(S)
CARSON, DA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
CARSON, DA
KAYE, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
KAYE, J
SEEGMILLER, JE
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
SEEGMILLER, JE
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1977,
74
(12)
: 5677
-
5681
[9]
INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYADENOSINE, AN INHIBITOR OF HTLV-III INFECTIVITY
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
COONEY, DA
AHLUWALIA, G
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
AHLUWALIA, G
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
MITSUYA, H
FRIDLAND, A
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
FRIDLAND, A
JOHNSON, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
JOHNSON, M
HAO, Z
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
HAO, Z
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
DALAL, M
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
BALZARINI, J
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
BRODER, S
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
JOHNS, DG
[J].
BIOCHEMICAL PHARMACOLOGY,
1987,
36
(11)
: 1765
-
1768
[10]
INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYCYTIDINE, AN INHIBITOR OF HTLV-III INFECTIVITY
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
COONEY, DA
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DALAL, M
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MITSUYA, H
MCMAHON, JB
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MCMAHON, JB
NADKARNI, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NADKARNI, M
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BALZARINI, J
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BRODER, S
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
JOHNS, DG
[J].
BIOCHEMICAL PHARMACOLOGY,
1986,
35
(13)
: 2065
-
2068
←
1
2
→
共 18 条
[1]
BOTH 2',3'-DIDEOXYTHYMIDINE AND ITS 2',3'-UNSATURATED DERIVATIVE (2',3'-DI-DEOXYTHYMIDINENE) ARE POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION INVITRO
BABA, M
论文数:
0
引用数:
0
h-index:
0
BABA, M
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
PAUWELS, R
HERDEWIJN, P
论文数:
0
引用数:
0
h-index:
0
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
DECLERCQ, E
DESMYTER, J
论文数:
0
引用数:
0
h-index:
0
DESMYTER, J
VANDEPUTTE, M
论文数:
0
引用数:
0
h-index:
0
VANDEPUTTE, M
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1987,
142
(01)
: 128
-
134
[2]
SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) BY 3'-AZIDO-2',3'-DIDEOXYGUANOSINE INVITRO
BABA, M
论文数:
0
引用数:
0
h-index:
0
BABA, M
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
PAUWELS, R
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
BALZARINI, J
HERDEWIJN, P
论文数:
0
引用数:
0
h-index:
0
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
DECLERCQ, E
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1987,
145
(03)
: 1080
-
1086
[3]
THE 2',3'-DIDEOXYRIBOSIDE OF 2,6-DIAMINOPURINE SELECTIVELY INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REPLICATION INVITRO
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
BALZARINI, J
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
PAUWELS, R
BABA, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
BABA, M
ROBINS, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
ROBINS, MJ
ZOU, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
ZOU, R
论文数:
引用数:
h-index:
机构:
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA
DECLERCQ, E
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1987,
145
(01)
: 269
-
276
[4]
POTENT AND SELECTIVE ANTI-HTLV-III/LAV ACTIVITY OF 2',3'-DIDEOXYCYTIDINENE, THE 2',3'-UNSATURATED DERIVATIVE OF 2',3'-DIDEOXYCYTIDINE
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BALZARINI, J
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
PAUWELS, R
HERDEWIJN, P
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DECLERCQ, E
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
COONEY, DA
KANG, GJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
KANG, GJ
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DALAL, M
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
JOHNS, DG
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BRODER, S
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1986,
140
(02)
: 735
-
742
[5]
BALZARINI J, 1987, MOL PHARMACOL, V32, P162
[6]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]
CARSON DA, 1980, J IMMUNOL, V124, P8
[8]
LYMPHO-SPECIFIC TOXICITY IN ADENOSINE-DEAMINASE DEFICIENCY AND PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY - POSSIBLE ROLE OF NUCLEOSIDE KINASE(S)
CARSON, DA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
CARSON, DA
KAYE, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
KAYE, J
SEEGMILLER, JE
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA
SEEGMILLER, JE
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1977,
74
(12)
: 5677
-
5681
[9]
INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYADENOSINE, AN INHIBITOR OF HTLV-III INFECTIVITY
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
COONEY, DA
AHLUWALIA, G
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
AHLUWALIA, G
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
MITSUYA, H
FRIDLAND, A
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
FRIDLAND, A
JOHNSON, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
JOHNSON, M
HAO, Z
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
HAO, Z
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
DALAL, M
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
BALZARINI, J
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
BRODER, S
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
JOHNS, DG
[J].
BIOCHEMICAL PHARMACOLOGY,
1987,
36
(11)
: 1765
-
1768
[10]
INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYCYTIDINE, AN INHIBITOR OF HTLV-III INFECTIVITY
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
COONEY, DA
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DALAL, M
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MITSUYA, H
MCMAHON, JB
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MCMAHON, JB
NADKARNI, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NADKARNI, M
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BALZARINI, J
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BRODER, S
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
JOHNS, DG
[J].
BIOCHEMICAL PHARMACOLOGY,
1986,
35
(13)
: 2065
-
2068
←
1
2
→